Twist Bioscience (TWST) Competitors $41.11 -0.21 (-0.51%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends TWST vs. IOVA, NVAX, VIR, RLAY, ALLO, RVMD, QGEN, ITCI, ROIV, and ASNDShould you be buying Twist Bioscience stock or one of its competitors? The main competitors of Twist Bioscience include Iovance Biotherapeutics (IOVA), Novavax (NVAX), Vir Biotechnology (VIR), Relay Therapeutics (RLAY), Allogene Therapeutics (ALLO), Revolution Medicines (RVMD), Qiagen (QGEN), Intra-Cellular Therapies (ITCI), Roivant Sciences (ROIV), and Ascendis Pharma A/S (ASND). These companies are all part of the "medical" sector. Twist Bioscience vs. Iovance Biotherapeutics Novavax Vir Biotechnology Relay Therapeutics Allogene Therapeutics Revolution Medicines Qiagen Intra-Cellular Therapies Roivant Sciences Ascendis Pharma A/S Iovance Biotherapeutics (NASDAQ:IOVA) and Twist Bioscience (NASDAQ:TWST) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations, community ranking and media sentiment. Do institutionals and insiders believe in IOVA or TWST? 77.0% of Iovance Biotherapeutics shares are owned by institutional investors. 12.1% of Iovance Biotherapeutics shares are owned by company insiders. Comparatively, 3.9% of Twist Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has preferable valuation and earnings, IOVA or TWST? Twist Bioscience has higher revenue and earnings than Iovance Biotherapeutics. Twist Bioscience is trading at a lower price-to-earnings ratio than Iovance Biotherapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIovance Biotherapeutics$1.19M2,084.80-$444.04M-$1.49-5.46Twist Bioscience$312.97M7.80-$204.62M-$3.60-11.42 Do analysts prefer IOVA or TWST? Iovance Biotherapeutics presently has a consensus target price of $22.33, indicating a potential upside of 174.37%. Twist Bioscience has a consensus target price of $51.78, indicating a potential upside of 25.95%. Given Iovance Biotherapeutics' stronger consensus rating and higher possible upside, equities analysts clearly believe Iovance Biotherapeutics is more favorable than Twist Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Iovance Biotherapeutics 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the media refer more to IOVA or TWST? In the previous week, Twist Bioscience had 23 more articles in the media than Iovance Biotherapeutics. MarketBeat recorded 30 mentions for Twist Bioscience and 7 mentions for Iovance Biotherapeutics. Twist Bioscience's average media sentiment score of 0.36 beat Iovance Biotherapeutics' score of 0.27 indicating that Twist Bioscience is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Iovance Biotherapeutics 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Twist Bioscience 12 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Does the MarketBeat Community favor IOVA or TWST? Iovance Biotherapeutics received 466 more outperform votes than Twist Bioscience when rated by MarketBeat users. Likewise, 74.44% of users gave Iovance Biotherapeutics an outperform vote while only 58.58% of users gave Twist Bioscience an outperform vote. CompanyUnderperformOutperformIovance BiotherapeuticsOutperform Votes56574.44% Underperform Votes19425.56% Twist BioscienceOutperform Votes9958.58% Underperform Votes7041.42% Is IOVA or TWST more profitable? Twist Bioscience has a net margin of -66.69% compared to Iovance Biotherapeutics' net margin of -451.25%. Twist Bioscience's return on equity of -32.27% beat Iovance Biotherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Iovance Biotherapeutics-451.25% -58.43% -45.48% Twist Bioscience -66.69%-32.27%-25.37% Which has more risk and volatility, IOVA or TWST? Iovance Biotherapeutics has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, Twist Bioscience has a beta of 1.78, meaning that its stock price is 78% more volatile than the S&P 500. SummaryIovance Biotherapeutics beats Twist Bioscience on 10 of the 18 factors compared between the two stocks. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TWST vs. The Competition Export to ExcelMetricTwist BioscienceBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.45B$2.93B$5.01B$8.81BDividend YieldN/A1.89%5.16%4.06%P/E Ratio-11.4245.25134.3717.77Price / Sales7.80360.241,158.6875.18Price / CashN/A160.0933.5332.53Price / Book5.163.734.674.68Net Income-$204.62M-$41.63M$119.07M$226.08M7 Day Performance5.52%-4.73%-1.83%-1.04%1 Month Performance-9.35%-6.53%-3.62%1.04%1 Year Performance73.39%25.63%31.63%26.28% Twist Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TWSTTwist Bioscience4.1382 of 5 stars$41.11-0.5%$51.78+25.9%+66.2%$2.45B$312.97M-11.42990Analyst ForecastAnalyst RevisionIOVAIovance Biotherapeutics4.0443 of 5 stars$8.14-0.6%$22.33+174.4%+48.3%$2.48B$1.19M-5.46500Options VolumeNVAXNovavax3.672 of 5 stars$8.06+0.8%$17.83+121.3%+41.4%$1.28B$983.71M0.001,543Analyst RevisionVIRVir Biotechnology3.019 of 5 stars$6.74-2.7%$36.40+440.1%-31.2%$954.40M$86.18M0.00587Analyst ForecastRLAYRelay Therapeutics3.2705 of 5 stars$4.66-2.9%$21.22+355.4%-44.5%$803.44M$25.55M0.00304Gap DownHigh Trading VolumeALLOAllogene Therapeutics2.7811 of 5 stars$2.05-3.3%$9.73+374.8%-31.4%$429.82M$90,000.00-1.31232Short Interest ↓RVMDRevolution Medicines2.7869 of 5 stars$57.07+1.1%$61.00+6.9%+162.6%$9.50B$11.58M0.00443QGENQiagen4.4347 of 5 stars$42.11+3.2%$50.88+20.8%+2.5%$9.31B$1.97B107.975,967Positive NewsHigh Trading VolumeITCIIntra-Cellular Therapies4.4721 of 5 stars$85.64+2.7%$97.23+13.5%+46.2%$9.08B$464.37M-98.44560Positive NewsROIVRoivant Sciences3.2837 of 5 stars$11.49+1.6%$17.93+56.0%+30.6%$8.36B$124.79M2.03860ASNDAscendis Pharma A/S3.0129 of 5 stars$124.380.0%$191.77+54.2%+32.7%$7.54B$288.08M-15.39640Analyst Upgrade Related Companies and Tools Related Companies Iovance Biotherapeutics Alternatives Novavax Alternatives Vir Biotechnology Alternatives Relay Therapeutics Alternatives Allogene Therapeutics Alternatives Revolution Medicines Alternatives Qiagen Alternatives Intra-Cellular Therapies Alternatives Roivant Sciences Alternatives Ascendis Pharma A/S Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TWST) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
